Cargando…
Can earlier biomarker measurements explain a treatment effect on diabetes incidence? A robust comparison of five surrogate markers
INTRODUCTION: We measured and compared five individual surrogate markers—change from baseline to 1 year after randomization in hemoglobin A1c (HbA1c), fasting glucose, 2-hour postchallenge glucose, triglyceride–glucose index (TyG) index, and homeostatic model assessment of insulin resistance (HOMA-I...
Autores principales: | Parast, Layla, Tian, Lu, Cai, Tianxi, Palaniappan, Latha P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619035/ https://www.ncbi.nlm.nih.gov/pubmed/37907279 http://dx.doi.org/10.1136/bmjdrc-2023-003585 |
Ejemplares similares
-
Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSM
por: Phillips, Andrew N., et al.
Publicado: (2015) -
Occupational distribution of metabolic syndrome prevalence and incidence differs by sex and is not explained by age and health behavior: results from 75 000 Dutch workers from 40 occupational groups
por: van Zon, Sander K R, et al.
Publicado: (2020) -
PM(2.5) exposure, glycemic markers and incidence of type 2 diabetes in two large Indian cities
por: Mandal, Siddhartha, et al.
Publicado: (2023) -
n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies
por: Qian, Frank, et al.
Publicado: (2021) -
Cognitive remediation in schizophrenia: the earlier the better?
por: Bellani, Marcella, et al.
Publicado: (2019)